ConductScience.org, home

Paper25978366

Modelling circulating tumour cells for personalised survival prediction in metastatic breast cancer.

Ascolani G and 2 others. PLoS Comput Biol, 2015. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Modelling circulating tumour cells for personalised survival prediction in metastatic breast cancer. Papers, record 25978366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25978366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modelling circulating tumour cells for personalised survival prediction in metastatic breast cancer.
PubMed
Journal
PLoS Comput Biol
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2024-03-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ascolani GGianluca
2Occhipinti AAnnalisa
3Liò PPietro

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Carcinoma, Ductal, BreastMajor topic
Models, BiologicalMajor topic
Neoplastic Cells, CirculatingMajor topic
Biomarkers, Tumor
Computer Simulation
Disease Progression
Female
Gene Expression Profiling
Humans
Kaplan-Meier Estimate
Survival Rate
Transforming Growth Factor beta

Source PubMed

Download CSV of topics

References69

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111961144Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP/ATP translocase by a nonhydrolyzable, adenine-containing metabolite.Mol Pharmacol2002https://conductscience.org/library/papers/11961144PubMed
224519765Too much mammography.BMJ2014https://conductscience.org/library/papers/24519765PubMed
39169439Thrombspondin acts via integrin-associated protein to activate the platelet integrin alphaIIbbeta3.J Biol Chem1997https://conductscience.org/library/papers/9169439PubMed
423918358Experiments on the role of deleterious mutations as stepping stones in adaptive evolution.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23918358PubMed
517365852Platelets possess functional TGF-beta receptors and Smad2 protein.Platelets2007https://conductscience.org/library/papers/17365852PubMed
622837985Adhesion receptors as therapeutic targets for circulating tumor cells.Front Oncol2012https://conductscience.org/library/papers/22837985PubMed
724599057Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer.PLoS One2014https://conductscience.org/library/papers/24599057PubMed
819589136Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.Breast Cancer Res2009https://conductscience.org/library/papers/19589136PubMed
924687923Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo.Clin Cancer Res2014https://conductscience.org/library/papers/24687923PubMed
1024824552Bisphosphonates in breast cancer.Int J Cancer2015https://conductscience.org/library/papers/24824552PubMed
1125171411Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.Cell2014https://conductscience.org/library/papers/25171411PubMed
1218175071The Met tyrosine kinase receptor in development and cancer.Cancer Metastasis Rev2008https://conductscience.org/library/papers/18175071PubMed
1325108081
Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study).
Bone2014https://conductscience.org/library/papers/25108081PubMed
1424586338Modeling TGF-β in early stages of cancer tissue dynamics.PLoS One2014https://conductscience.org/library/papers/24586338PubMed
1512742232Nitrogen-containing bisphosphonates induce S-phase cell cycle arrest and apoptosis of myeloma cells by activating MAPK pathway and inhibiting mevalonate pathway.Cell Signal2003https://conductscience.org/library/papers/12742232PubMed
1619584232Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity.Mol Cancer Ther2009https://conductscience.org/library/papers/19584232PubMed
1710856220Role of CD47 as a marker of self on red blood cells.Science2000https://conductscience.org/library/papers/10856220PubMed
1821611158Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer.PLoS One2011https://conductscience.org/library/papers/21611158PubMed
1919487818The basics of epithelial-mesenchymal transition.J Clin Invest2009https://conductscience.org/library/papers/19487818PubMed
209548474T cell stimulation via CD47: agonistic and antagonistic effects of CD47 monoclonal antibody 1/1A4.J Immunol1997https://conductscience.org/library/papers/9548474PubMed

See all 69 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
36227551Machine Learning Methods for Survival Analysis with Clinical and Transcriptomics Data of Breast Cancer.Methods Mol Biol2023https://conductscience.org/library/papers/36227551PubMed
33674749Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance.Oncogene2021https://conductscience.org/library/papers/33674749PubMed
32258970Modeling the Human Bone-Tumor Niche: Reducing and Replacing the Need for Animal Data.JBMR Plus2020https://conductscience.org/library/papers/32258970PubMed
31345216Modeling breast cancer progression to bone: how driver mutation order and metabolism matter.BMC Med Genomics2019https://conductscience.org/library/papers/31345216PubMed
29207686Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells.Oncotarget2017https://conductscience.org/library/papers/29207686PubMed
27084578Signatures of breast cancer metastasis at a glance.J Cell Sci2016https://conductscience.org/library/papers/27084578PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25978366

GET https://conductscience.org/api/papers/v1/25978366/references?page=2